Anti-CD25 Treatment Depletes Treg Cells and Decreases Disease Severity in Susceptible and Resistant Mice Infected with Paracoccidioides brasiliensis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Felonato, Maíra ^a   Pina, Adriana ^a   de Araujo, Eliseu Frank ^a   Loures, Flávio V ^a   Bazan, Silvia B ^a   Feriotti, Cláudia ^a   Calich, Vera L G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; KYNURENINE; LATENCY ASSOCIATED PEPTIDE; NITRIC OXIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

A J MOUSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 10 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; FUNGUS GROWTH; LEUKOCYTE COUNT; LIVER; LUNG; LUNG MYCOSIS; MACROPHAGE; MORTALITY; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SOUTH AMERICAN BLASTOMYCOSIS; SPLEEN; T CELL DEPLETION;

ANIMALS; ANTIBODIES; CELL MOVEMENT; DISEASE RESISTANCE; DISEASE SUSCEPTIBILITY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNITY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KYNURENINE; LIVER; LUNG; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

MUS; PARACOCCIDIOIDES BRASILIENSIS;

EID: 84870585635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051071     Document Type: Article

References (62)

1. Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon NL, et al. (1987) Paracoccidioidomycosis: a recently proposed classification on its clinical forms. Soc Bras Med Trop 20: 129-133.
2. Mamoni RL, Blotta MH, (2005) Kinetics of cytokines and chemokines gene expression distinguishes Paracoccidioides brasiliensis infection from disease. Cytokine 32: 20-29.
3. Benard G, Romano CC, Cacere CR, Juvenale M, Mendes-Giannini MJ, et al. (2001) Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine 13: 248-252.
4. Calich VLG, Singer-Vermes LM, Burger E, (1985) Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br J Exp Pathol 66: 585-594.
5. Cano LE, Singer-Vermes LM, Vaz CAC, Russo M, Calich VLG, (1995) Pulmonary paracoccidioidomycosis in resistant and susceptible mice: relationship among progression of infection, bronchoalveolar cell activation, cellular immune response and specific isotype patterns. Infect Immun 63: 1777-1783.
6. Cano LE, Kashino SS, Arruda C, André DC, Xidieh CF, et al. (1998) Protective role of gamma-interferon in experimental pulmonary paracoccidioidomycosis. Infec Immun 66: 800-806.
7. Chiarella AP, Arruda C, Pina A, Costa TA, Ferreira RC, et al. (2007) The relative importance of CD4+ and CD8+ T cell in immunity to pulmonary paracoccidioidomycosis. Microbes Infect 9: 1078-1088.
8. Calich VLG, Blotta MHSL (2005) Pulmonary paracoccidioidomycosis. In Fungal Immunology: From an Organ Perspective. Fidel, PL, Huffnagle, GB, editors. Springer, New York. 201-228.
9. Calich VL, Costa TA, Felonato M, Arruda C, Bernardino S, et al. (2008) Innate immunity to Paracoccidioides brasiliensis. Mycopathologia 165: 223-236.
10. Cano LE, Singer-Vermes LM, Costa TA, Mengel JO, Xidieh CF, et al. (2000) Depletion of CD8+ T cells in vivo impairs host defense of mice resistant and susceptible to pulmonary paracoccidioidomycosis. Infect Immun 68: 352-359.
11. Nascimento FRF, Calich VLG, Rodrigues D, Russo M, (2002) Dual role for nitric oxide in Paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J Immunol 168: 4593-4600.
12. McHugh RS, Shevach EM, (2002) The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol 110: 693-702.
13. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, et al. (2001) Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182: 18-32.
14. Belkaid Y, Rouse BT, (2005) Natural regulatory T cells in infectious diseases. Nature Immunol 6: 353-360.
15. Rudensky AY, (2011) Regulatory T cells and Foxp3. Immunol Rev 241: 260-268.
16. Sakaguchi S, (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352.
17. Belkaid Y, Tarbell K, (2009) Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol 27: 551-589.
18. Miyara M, Sakaguchi S, (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13: 108-116.
19. Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, et al. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 24: 145-159.
20. Shevach EM, Stephens GL, (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6: 613-618.
21. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
22. Ohkura N, Sakaguchi S, (2011) Maturation of regulatory T cells. Nat Immunol 12: 283-284.
23. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
24. Sakaguchi S, (2003) The origin of Foxp3-expressing CD4+ regulatory T cells: thymus or periphery. J Clin Invest 112: 1310-1312.
25. Fontenot JD, Dooley JL, Farr AG, Rudensky AY, (2005) Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 202: 901-906.
26. Jonuleit H, Schmitt E, (2003) The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171: 6323-6327.
27. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
28. Johanns TM, Ertelt JM, Rowe JH, Way SS, (2010) Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 6: e1001043.
29. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
30. Belkaid Y, Piccirilo AC, Mendez S, Shevack E, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
31. Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, et al. (2002) B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 169: 6298-6308.
32. Hori S, Carvalho TL, Demengeot J, (2002) CD25+CD4+ regulatory suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32: 1282-1291.
33. Montagnoli C, Fallarino F, Gaziano R, Bozza S, Bellocchio S, et al. (2006) Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. 2006. J Immunol 176: 1712-1723.
34. Kroetz DN, Deepe GS, (2010) CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection. J Immunol 184: 5224-5231.
35. Cavassani KA, Campanelli AP, Moreira AP, Vancim JO, Vitali LH, et al. (2006) Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J Immunol 177: 5811-5818.
36. Ferreira MC, de Oliveira RT, da Silva RM, Blotta MH, Mamoni RL, (2010) Involvement of regulatory T cells in the immunosuppression characteristic of patients with paracoccidioidomycosis. Infect Immun 78: 4392-4401.
37. Moreira AP, Cavassani KA, Massafera-Tristão FS, Campanelli AP, Martinez R, et al. (2008) CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression. J Immunol 180: 3049-3056.
38. Loures FV, Pina A, Felonato M, Calich VL, (2009) TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 183: 1279-1290.
39. Loures FV, Pina A, Felonato M, Araújo EF, Leite KR, et al. (2010) Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect Immun 78: 1078-1088.
40. Felonato M, Pina A, Bernardino S, Loures FV, de Araujo EF, et al. (2010) CD28 exerts protective and detrimental effects in a pulmonary model of paracoccidioidomycosis. Infect Immun 78: 4922-4935.
41. Loures FV, Pina A, Felonato M, Feriotti C, de Araujo EF, et al. (2011) MyD88 signaling is required for efficient innate and adaptive immune responses to Paracoccidioides brasiliensis infection. Infect Immun 79: 2470-2480.
42. Kashino SS, Singer-Vermes LM, Calich VLG, Burger E, (1990) Alterations in the pathogenicity of one Paracoccidioides brasiliensis isolate do not correlate with its in vitro growth. Mycopathology 111: 173-180.
43. Fava Netto C, Vegas VS, Sciannaméa IM, Guarnieri EDB, (1969) Antígeno polissacarídico do Paracoccidioides brasiliensis. Estudo do tempo de cultivo do P. brasiliensis necessário ao preparo do antígeno. Rev Inst Med Trop Sao Paulo 11: 177-181.
44. Zelenay S, Demengeot J, (2006) Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells". J Immunol 177: 2036-2037.
45. Couper KN, Blount DG, de Souza JB, Suffia I, Belkaid Y, et al. (2007) Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol 178: 4136-4146.
46. Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VLG, (1992) The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J Med Vet Mycol 30: 261-264.
47. Bonifazi P, Zelante T, D'Angelo C, De Luca A, Moretti S, et al. (2009) Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol 2: 362-374.
48. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, et al. (2009) IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183: 2475-2483.
49. De Luca A, Montagnoli C, Zelante T, Bonifazi P, Bozza S, et al. (2007) Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 179: 5999-6008.
50. De Luca A, Bozza S, Zelante T, Zagarella S, D'Angelo C, et al. (2010) Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell Mol Immunol 7: 459-470.
51. Brummer E (1994) Interaction of Paracoccidioides brasiliensis with host defense cells. In: Franco M, Lacaz, CS, Restrepo, A, del Negro G, editors. Paracoccidioidomycosis. Boca Raton, Florida: CRC Press. 213-224.
52. Pina A, Bernardino S, Calich VLG, (2008) Alveolar macrophages from susceptible mice are more competent than those of resistant mice to control initial Paracoccidioides brasiliensis infection. J Leukoc Biol 83: 1088-1099.
53. Neill DR, Fernandes VE, Wisby L, Haynes AR, Ferreira DM, et al. (2012) T Regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PloS Pathog 8: e1002660.
54. Chen X, Oppenheim JJ, Howard OMZ, (2005) BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder than C57BL/6 mice. J Leukoc Biol 78: 114-121.
55. Rowe JH, Ertelt JM, Way SS, (2011) Foxp3+ regulatory T cells, immune stimulation and host defense against infection. Immunol 136: 1-10.
56. McKinley L, Logar AJ, McAllister F, Zheng M, Steele C, et al. (2006) Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J Immunol 177: 6215-6226.
57. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-86.
58. Bettelli EY, Carrier W, Gao T, Korn TB, Strom M, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441: 235-238.
59. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, et al. (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediates pathology. Nat Immunol 8: 1390-1397.
60. Pallota MT, Orabona C, Volpi C, Vacca C, D'Angelo C, et al. (2011) Indoleamine 2,3-dioxygenase is a signaling protein in long term tolerance by dendritic cells. Nat Immun. 12: 870-878.
61. Fallarino F. Grohmann U, Puccetti P, (2012) Indoleamine 2,3-dioxygenase:from catalyst to signaling function. Eur J Immunol 42: 1932-1937.
62. Romani L, (2011) Immunity to fungal infections. Nat Rev Immunol 11: 275-288.